Related references
Note: Only part of the references are listed.Pan-DR-Binding Hsp60 Self Epitopes Induce an Interleukin-10-Mediated Immune Response in Rheumatoid Arthritis
Huib de Jong et al.
ARTHRITIS AND RHEUMATISM (2009)
Current concepts in the pathogenesis of early rheumatoid arthritis
Arthur G. Pratt et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)
Treatment of rheumatoid arthritis: state of the art 2009
Ronald F. van Vollenhoven
NATURE REVIEWS RHEUMATOLOGY (2009)
Th17 cells in immunity and autoimmunity
M. Oukka
ANNALS OF THE RHEUMATIC DISEASES (2008)
The good, the bad and the ugly: how altered peptide ligands modulate immunity
Maria Katsara et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
HSP60 as a Target of Anti-Ergotypic Regulatory T Cells
Francisco J. Quintana et al.
PLOS ONE (2008)
The role of T cells in rheumatoid arthritis: new subsets and new targets
Myew-Ling Toh et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Suppression of rnyasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells
BV Aruna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis
S Kamphuis et al.
LANCET (2005)
The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions
AJ Kinder et al.
RHEUMATOLOGY (2005)
Heat shock proteins as endogenous adjuvants in sterile and septic inflammation
FJ Quintana et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles
PA Reche et al.
IMMUNOGENETICS (2004)
DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: Identification of a regulatory HSP60 peptide
FJ Quintana et al.
JOURNAL OF IMMUNOLOGY (2003)
MHCPred: a server for quantitative prediction of peptide-MHC binding
PP Guan et al.
NUCLEIC ACIDS RESEARCH (2003)
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2003)
DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes
FJ Quintana et al.
JOURNAL OF IMMUNOLOGY (2002)
Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide
DG Alleva et al.
DIABETES (2002)
ProPred: prediction of HLA-DR binding sites
H Singh et al.
BIOINFORMATICS (2001)
Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?
M Peakman et al.
IMMUNOLOGY (2001)
Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities
SM Anderton
IMMUNOLOGY (2001)
Antigen-specific immunomodulation via altered peptide ligands
B Bielekova et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
The genetic and immunopathological processes underlying collagen-induced arthritis
JA Luross et al.
IMMUNOLOGY (2001)
Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-γ and are protective in adjuvant arthritis
AGA Paul et al.
JOURNAL OF IMMUNOLOGY (2000)
A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?
AGA Paul et al.
INTERNATIONAL IMMUNOLOGY (2000)
Stress proteins as targets for anti-inflammatory therapies
W van Eden
DRUG DISCOVERY TODAY (2000)
Share Paper
